Low dose Aspirin (81 mg or less)

Rather than an established standalone therapeutic class, "Low dose Aspirin (81 mg or less)" represents a specific dosage-defined administrative grouping within the broader antiplatelet and nonsteroidal anti-inflammatory drug (NSAID) classes

At these lower doses, aspirin selectively and irreversibly acetylates cyclooxygenase-1 (COX-1), which suppresses platelet production of thromboxane A2 and thereby inhibits platelet aggregation Formulations in this category are primarily utilized for cardioprotective and antithrombotic therapy, including the secondary prevention of cardiovascular and cerebrovascular events, as well as risk reduction in high-risk obstetric conditions like preeclampsia

At these lower doses, aspirin selectively and irreversibly acetylates cyclooxygenase-1 (COX-1), which suppresses platelet production of thromboxane A2 and thereby inhibits platelet aggregation

Formulations in this category are primarily utilized for cardioprotective and antithrombotic therapy, including the secondary prevention of cardiovascular and cerebrovascular events, as well as risk reduction in high-risk obstetric conditions like preeclampsia

Formulations in this category are primarily utilized for cardioprotective and antithrombotic therapy, including the secondary prevention of cardiovascular and cerebrovascular events, as well as risk reduction in high-risk obstetric conditions like preeclampsia

Formulations in this category are primarily utilized for cardioprotective and antithrombotic therapy, including the secondary prevention of cardiovascular and cerebrovascular events, as well as risk reduction in high-risk obstetric conditions like preeclampsia